APA aipamena

Liang, W., He, Q., Chen, Y., Zou, X., Hamblin, L., & He, J. (2015). Discontinuing epidermal growth factor receptor-tyrosine kinase inhibitor during second-line chemotherapy: Is the evidence strong enough? Ann Transl Med.

Chicago Style aipamena

Liang, Wenhua, Qihua He, Ying Chen, Xusen Zou, Lindsey Hamblin, and Jianxing He. "Discontinuing Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitor During Second-line Chemotherapy: Is the Evidence Strong Enough?" Ann Transl Med 2015.

MLA aipamena

Liang, Wenhua, et al. "Discontinuing Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitor During Second-line Chemotherapy: Is the Evidence Strong Enough?" Ann Transl Med 2015.